On Invalid Date, Omega Therapeutics (NASDAQ: OMGA) reported Q3 2023 earnings per share (EPS) of -$0.40, up 25.93% year over year. Total Omega Therapeutics earnings for the quarter were -$22.25 million. In the same quarter last year, Omega Therapeutics's earnings per share (EPS) was -$0.54.
As of Q1 2024, Omega Therapeutics's earnings has grown year over year. Omega Therapeutics's earnings in the past year totalled -$108.04 million.
What is OMGA's earnings date?
Omega Therapeutics's earnings date is Invalid Date. Add OMGA to your watchlist to be reminded of OMGA's next earnings announcement.
What was OMGA's revenue last quarter?
On Invalid Date, Omega Therapeutics (NASDAQ: OMGA) reported Q3 2023 revenue of $831.00 thousand up 39.66% year over year. In the same quarter last year, Omega Therapeutics's revenue was $595.00 thousand.
What was OMGA's revenue growth in the past year?
As of Q1 2024, Omega Therapeutics's revenue has grown 91.57% year over year. This is 77.73 percentage points lower than the US Biotechnology industry revenue growth rate of 169.3%. Omega Therapeutics's revenue in the past year totalled $2.84 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.